Ri.MED Symposium 2018 "Cancer Immunotherapy: Recent Progress and Future Challenges"

October, 12th, 2018
Sala Mattarella, Palazzo Dei Normanni
Palermo, Italy

The 12th Ri.MED annual scientific Symposium “Cancer Immunotherapy: Recent Progress and Future Challenges”. took place on October 12th, 2018 in Palermo, in the marvelous setting of Palazzo dei Normanni, seat of the Sicilian Parliament.

This meeting brought together a panel of internationally recognized cancer immunologists and immunotherapists for a one day meeting in Palermo, Italy, that will cover cutting-edge basic and translational research observations and recent clinical studies focused on cancer immunology and immunotherapy.

The Symposium was preceded on October 11th 2018 by the Ri.MED Retreat at which the Ri.MED investigators and a few special guests will present their research.

Download the program

KEYNOTE SPEAKERS:
Dario Vignali, PhD
Scientific Director, Fondazione Ri.MED
The Frank Dixon Chair in Cancer Immunology, Vice Chair and Professor of Immunology, Department of Immunology, University of Pittsburgh School of Medicine,
and Co-Leader, Cancer Immunology and Immunotherapy Program,
Co-Director, Tumor Microenvironment Center, UPMC Hillman Cancer Center. Pittsburgh, USA

Robert Louis Ferris, MD, PhD
Director, UPMC Hillman Cancer Center; Co-Director, Tumor Microenvironment Center
Hillman Professor of Oncology, Associate Vice-Chancellor for Cancer Research
Professor of Oncology, Otolaryngology, Immunology, and Radiation Oncology, University of Pittsburgh School of Medicine

SPEAKERS:
Ana Carrizosa Anderson, Ph.D.
Associate Professor of Neurology, Broad Institute, Harvard Medical School and Brigham and Women’s Hospital, Boston, USA

Paolo Ascierto, MD
Director, Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione “G. Pascale”, Napoli – Italy

Vincenzo Bronte, MD, PhD
Professor, Department of Medicine, University Hospital University of Verona

Tullia Bruno, PhD
Research Assistant Professor of Immunology, UPMC Hillman Cancer Center, Pittsburgh, USA

Udai S. Kammula, MD, FACS
Director, Solid Tumor Cell Therapy Program,UPMC Hillman Cancer Center, USA

Ignacio Melero, MD, PhD
Co-Director, Immunology and Immunotherapy Service
Senior Researcher, Clínica Universidad de Navarra and Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain

Sergio Quezada, Ph.D.
Group Leader, Immune Regulation and Tumor Immunotherapy Lab
University College London Cancer Institute